PILAR HOFFSTEN: Open Payments
NPI 1386074284 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 11 payments from 6 companies in 2025. Trend: 2023 $398 · 2024 $181 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $165 |
| Novo Nordisk Inc | 1 | $106 |
| Vanda Pharmaceuticals Inc. | 3 | $92 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Exact Sciences Corporation | 1 | $19 |
| Corcept Therapeutics | 1 | $16 |
Products named: ABILIFY MAINTENA, Wegovy, FANAPT, AUSTEDO XR, REXULTI, UZEDY, Korlym.
Industry payments across AZ — which companies pay providers there.
